Keytruda, first approved in 2014, is an immunotherapy drug that stimulates the body‘s immune system to detect and kill cancer cells.
Clinicians may now use the drug, in combination with Eli Lilly’s chemotherapy drug Alimta, for previously untreated patients with advanced lung cancer.
Keytruda is already approved to treat some types of non-small cell lung cancer, melanoma and head and neck cancer, among other illnesses.
More articles on supply chain:
WHO calls for global drug price transparency
Patients barter for costly medications on Facebook
PhRMA issues new membership criteria, boots more than 20 drugmakers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
